Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,610.00    -80.00 (-1.41%)
Bid:
5,620.00
Ask:
5,630.00
Spread: 10.00 (0.178%)
Market Cap: £3.00b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Director Appointments

23 Jun 2022 07:00

RNS Number : 8624P
Cranswick PLC
23 June 2022
 

23 June 2022

Cranswick plc(the "Company" or "the Group")

Director Appointments

Cranswick plc, a leading UK food producer, announces the appointment of Yetunde Hofmann as an independent Non-Executive Director of the Company and of Christopher Aldersley as an Executive Director of the Company, both with effect from 1 August 2022.

Yetunde Hofmann

Yetunde is the Managing Director of Synchrony Development Consulting, an international leadership and change consultancy that partners with leaders to facilitate strategy, change, diversity and inclusion and the founder of Solaris Global Executive Leadership Development. She is also a Trustee at the Institute of Business Ethics (IBE) and is a visiting fellow at the University of Reading's Henley Business School of Marketing and Reputation.

On appointment, Yetunde will become a member of the Audit, Remuneration, Nomination and ESG committees.

Yetunde is an independent Non-Executive Director at Treatt plc. No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Yetunde Hofmann's appointment as a Non-Executive Director of the Company.

Christopher Aldersley

Chris joined Cranswick in 1998 and since then has undertaken a variety of senior management roles, becoming the Group's Chief Operating Officer in 2015. Chris has responsibility for managing the operations at the Group's four primary processing and sixteen added value facilities and also for its agricultural operations, which support the Group's vertically integrated supply chain strategy.

The appointment of Chris to the Board recognises his contribution to the Group and central importance of his role going forward as a member of the Board to the delivery of the Group's long-term strategy.

On appointment, Chris will become a member of the ESG committee.

No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Chris Aldersley's appointment as an Executive Director of the Company.

Tim Smith, Chairman of Cranswick plc, commented:

"I am delighted that Yetunde and Chris will join our Board.

"Yetunde's experience will complement our existing Board. She has an established track record of mentoring and developing performance, talent and leadership strategies across a range of organisations, which will be invaluable to Cranswick.

"Chris's role at Cranswick has grown with the rapid development of the Group and he has been central to facing the challenges presented in recent times by Brexit and the COVID-19 pandemic. Chris helps deliver our Second Nature sustainability strategy. I am pleased his contribution is recognised with his appointment to the Board.".

Enquiries:

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Powerscourt

020 7250 1446

Nick Dibden / Nick Hayns/Chloe Retief

cranswick@powerscourt-group.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFEERTIFFIF
Date   Source Headline
30th Jun 20092:49 pmRNSTotal Voting Rights
30th Jun 20092:47 pmRNSTotal Voting Rights
24th Jun 20097:00 amRNSCompletion of Acquisition
16th Jun 20095:38 pmRNSHolding(s) in Company
9th Jun 20093:25 pmRNSMerger Update
2nd Jun 20099:29 amRNSTotal Voting Rights
1st Jun 20093:22 pmRNSDirector Appointment
18th May 20097:00 amRNSFinal Results
7th May 20094:57 pmRNSCompletion of Disposal
1st May 20095:17 pmRNSTotal Voting Rights
29th Apr 20094:35 pmRNSPrice Monitoring Extension
24th Apr 20095:04 pmRNSCompletion of Disposal
20th Apr 20092:32 pmRNSAdditional Listing
20th Apr 20097:00 amRNSDisposal
8th Apr 20093:00 pmRNSMerger Update
6th Apr 20097:00 amRNSAcquisition
2nd Apr 20094:15 pmRNSBlocklisting Interim Review
30th Mar 200912:54 pmRNSDirector/PDMR Shareholding
30th Mar 200911:57 amRNSTotal Voting Rights
30th Mar 200911:55 amRNSDirector/PDMR Shareholding
30th Mar 20097:00 amRNS4th Quarter Trading Update and Board Change
11th Feb 20093:14 pmRNSDirector/PDMR Shareholding
11th Feb 20093:11 pmRNSDirector/PDMR Shareholding
11th Feb 20093:04 pmRNSDirector/PDMR Shareholding
30th Jan 20097:00 amRNSInterim Management Statement
28th Jan 20094:32 pmRNSHolding(s) in Company
20th Jan 20098:48 amRNSAdditional Listing
2nd Dec 20084:35 pmRNSPrice Monitoring Extension
24th Nov 20084:55 pmRNSSecond Price Monitoring Extn
24th Nov 20084:39 pmRNSPrice Monitoring Extension
17th Nov 20087:00 amRNSInterim Results
11th Nov 20083:50 pmRNSTotal Voting Rights
20th Oct 20084:40 pmRNSPrice Monitoring Extension
7th Oct 20087:00 amRNSTrading Statement
5th Sep 20084:21 pmRNSAdditional Listing
14th Aug 200810:13 amRNSAGM Statement
29th Jul 20084:52 pmRNSDirector/PDMR Shareholding
29th Jul 20084:51 pmRNSDirector/PDMR Shareholding
29th Jul 20084:50 pmRNSDirector/PDMR Shareholding
29th Jul 20084:45 pmRNSDirector/PDMR Shareholding
29th Jul 20084:35 pmRNSDirector/PDMR Shareholding
28th Jul 20087:00 amRNSFirst Quarter Trading Stateme
19th May 20087:00 amRNSFinal Results
7th Apr 20087:00 amRNSFourth Quarter Trading Update
27th Mar 20083:21 pmRNSDirector/PDMR Shareholding
18th Mar 200812:50 pmRNSDirectorate Change
14th Mar 20088:53 amRNSDirector/PDMR Shareholding
14th Mar 20088:48 amRNSDirector/PDMR Shareholding
6th Mar 20085:19 pmRNSDirector/PDMR Shareholding
6th Mar 20085:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.